99-21585. Importation of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 64, Number 161 (Friday, August 20, 1999)]
    [Notices]
    [Pages 45565-45566]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-21585]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Importation of Controlled Substances; Notice of Registration
    
        By Notice dated May 14, 1999, and published in the Federal Register 
    on May 25, 1999 (64 FR 28214), Research Biochemicals, Limited 
    Partnership, 1-3 Strathmore Road, Natick, Massachusetts 01760, made 
    application by renewal to the Drug Enforcement Administration (DEA) to 
    be registered as an importer of the basic classes of controlled 
    substances listed below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule
    ------------------------------------------------------------------------
    Cathinone (1235)...........................  I
    Methcathinone (1237).......................  I
    Aminorex (1585)............................  I
    Methaqualone (2565)........................  I
    Alpha-Ethyltryptamine (7249)...............  I
    Ibogaine (7260)............................  I
    
    [[Page 45566]]
    
     
    Lysergic acid diethylamide (7315)..........  I
    Marihuana (7360)...........................  I
    Tetrahydrocannabinols (7370)...............  I
    Mescaline (7381)...........................  I
    Bufotenine (7433)..........................  I
    Etonitazene (9624).........................  I
    Methylphenidate (1724).....................  II
    Secobarbital (2315)........................  II
    Glutethimide (2550)........................  II
    Diprenorphine (9058).......................  II
    Oxycodone (9143)...........................  II
    Hydromorphone (9150).......................  II
    Diphenoxylate (9170).......................  II
    Hydrocodone (9193).........................  II
    Levomethorphan (9210)......................  II
    Levorphanol (9220).........................  II
    Meperidine (9230)..........................  II
    Metazocine (9240)..........................  II
    Methadone (9250)...........................  II
    Dextropropoxyphene, bulk (non-dosage forms)  II
     (9273).
    Thebaine (9333)............................  II
    Levo-alphacetylmethadol (LAAM) (9648)......  II
    Oxymorphone (9652).........................  II
    ------------------------------------------------------------------------
    
        The firm plans to import small quantities of the listed controlled 
    substances to manufacture laboratory reference standards and 
    neurochemicals.
        No comments or objections have been received. DEA has considered 
    the factors in title 21, United States Code, Section 823(a) and 
    determined that the registration of Research Biochemicals to import the 
    listed controlled substances is consistent with the public interest and 
    with United States obligations under international treaties, 
    conventions, or protocols in effect on May 1, 1971, at this time. DEA 
    has investigated Research Biochemicals on a regular basis to ensure 
    that the company's continued registration is consistent with the public 
    interest. These investigations have included inspection and testing of 
    the company's physical security systems, audits of the company's 
    records, verification of the company's compliance with state and local 
    laws, and a review of the company's background and history. Therefore, 
    pursuant to Section 1008(a) of the Controlled Substances Import and 
    Export Act and in accordance with Title 21, Code of Federal 
    Regulations, Section 1301.34, the above firm is granted registration as 
    an importer of the basic classes of controlled substances listed above.
    
        Dated: August 5, 1999.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 99-21585 Filed 8-19-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
08/20/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-21585
Pages:
45565-45566 (2 pages)
PDF File:
99-21585.pdf